Oleksandr Severin

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

High Performance Liquid Chromatography

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Oleksandr Severin, Stepan Pilyo, Maryna Kachaeva, Victor Zhirnov, Diana Hodyna, Oksana Bahrieieva, Volodymyr S Brovarets
Synthesis, characterization of novel N-(4-cyano-1,3-oxazol-5-yl)sulfonamide derivatives and in vitro screening their activity against NCI-60 cancer cell lines. ChemMedChem 19 (5) (2024)
Oleksandr Severin, Stepan Pilyo, Maryna Kachaeva, Victor Zhirnov, Diana Hodyna, Oksana Bahrieieva, Volodymyr S Brovarets
Synthesis, characterization of novel N-(4-cyano-1,3-oxazol-5-yl)sulfonamide derivatives and in vitro screening their activity against NCI-60 cancer cell lines. ChemMedChem 19 (5) (2024)
Oleksandr Severin, Stepan Pilyo, Maryna Kachaeva, Victor Zhirnov, Diana Hodyna, Oksana Bahrieieva, Volodymyr S Brovarets
Synthesis, characterization of novel N-(4-cyano-1,3-oxazol-5-yl)sulfonamide derivatives and in vitro screening their activity against NCI-60 cancer cell lines. ChemMedChem (2024)
Oleksandr Severin, Stepan Pilyo, Maryna Kachaeva, Victor Zhirnov, Diana Hodyna, Oksana Bahrieieva, Volodymyr S Brovarets
Synthesis, characterization of novel N-(4-cyano-1,3-oxazol-5-yl)sulfonamide derivatives and in vitro screening their activity against NCI-60 cancer cell lines. ChemMedChem 19 (5) (2024)
Oleksandr Severin, Stepan Pilyo, Maryna Kachaeva, Victor Zhirnov, Diana Hodyna, Oksana Bahrieieva, Volodymyr S Brovarets
Synthesis, characterization of novel N-(4-cyano-1,3-oxazol-5-yl)sulfonamide derivatives and in vitro screening their activity against NCI-60 cancer cell lines. ChemMedChem 19 (5) (2024)